MedTrace Logo

Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship

NCT03674437 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 441

Last updated 2025-11-14

No results posted yet for this study

Summary

The purpose of this study is to measure changes in cognitive (mental) function in cancer survivors using a brief, reliable, game-like set of tests that can be completed outside the clinic, as an alternative to traditional neurocognitive assessments. This set of computerized tests, the Cogsuite Assessment, is expected to improve our ability to identify cognitive impairments in people who have been treated for cancer, so that we can (1) learn more about which cognitive functions are affected by cancer treatment, and (2) guide that treatment more effectively.

Conditions

  • Breast Cancer Survivors

Interventions

BEHAVIORAL

Traditional Neurocognitive Assessments

Traditional Neurocognitive Assessments given with pen and paper

BEHAVIORAL

Online Cognitive Battery (Cogsuite)

Cognition (Cogsuite) for a battery that consists of seven measurements.

Sponsors & Collaborators

Principal Investigators

  • James Root, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-11
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03674437 on ClinicalTrials.gov